摘要
目的:探讨提高抗病毒疗效和服药依从性,延缓病毒耐药发生的方法。方法:377名来源于同一乡村的HIV感染者,分为督导治疗组(n=134)和未督导治疗组(n=243),均给予HAART治疗,仅督导治疗组患者给予严格督导治疗。分别于治疗后第1、2、3、6、9和12个月,抽取外周血,应用PCR检测HIV-RNA载量,流式细胞仪检测CD4+、CD8+T淋巴细胞数量,血常规检测白细胞数量变化。结果:随着治疗时间的延长,2组患者外周血CD4+、CD8+T淋巴细胞及白细胞数量均逐渐上升;2组间比较,差异无统计学意义。2组患者外周血HIV-RNA载量差异有统计学意义(F组间=3.781,F时间=2.561,F交互=352.79,P﹤0.05);治疗后6、9和12个月督导治疗组高于未督导治疗组。结论:督导治疗有利于持续抗病毒疗效,延缓耐药毒株的发生。
Aim: To seek the suitable method for elevating the effects of HAART and delaying the emergence of the resistance. Methods: 377 AIDS patients from the same area were divided into the full supervision ( n = 134) and non-full supervision ( n = 134) treatment groups. All the patients were given the same HAART traerment for 12 months. At 1,2,3, 6,9,12 months after treatment,the HIV-RNA load were detected by PCR ,CD4 + ,CD8 + T cells were detected by flow cy- tometry ,and white blood cell ( WBC) were detected by routine blood test. Results: The counts of CD4 + ,CD8 + T cells elevated in the two groups ,and there were no obviously different. The HIV-RNA load between the two groups were different ( F group = 3. 781,F time = 2. 561,F interaction = 352. 791,P 0. 05) ; Non-full supervision treatment group was higher than the full supervision treatment group at 6,9,12 months after treatment. Conclusion: The full supervision treatment could delay the emergence of resistance and prolong the effect of HAART.
出处
《郑州大学学报(医学版)》
CAS
北大核心
2013年第2期235-238,共4页
Journal of Zhengzhou University(Medical Sciences)
基金
国家"十.五"攻关课题基金资助项目200413A719A13-05
200413A719A10
国家自然科学基金资助项目30472031
关键词
人类免疫缺陷病毒
高效逆转录病毒治疗
耐药
human immunodeficiency virus
highly active antiretroviral therapy
resistance